Amlodipine
From Wikipedia, the free encyclopedia
Amlodipine
|
|
Systematic (IUPAC) name | |
3-ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2- chlorophenyl)-1,4-dihydro-6-methyl-3,5- pyridinedicarboxylate benzenesulfonate |
|
Identifiers | |
CAS number | 88150-42-9 |
ATC code | C08CA01 |
PubChem | 2162 |
DrugBank | APRD00520 |
Chemical data | |
Formula | C20H25ClN2O5.C6H6O3S |
Mol. weight | 408.879 g/mol |
Pharmacokinetic data | |
Bioavailability | 64 to 90% |
Metabolism | Hepatic |
Half life | 30 to 50 hours |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. | |
Legal status | |
Routes | Oral (tablets) |
Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc® in North America and as Istin® in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell.
Contents |
[edit] Indications
- hypertension
- prophylaxis of angina
[edit] Cautions
- hepatic impairment
- pregnancy
[edit] Contra-indications
[edit] Side effects
Some side effects of the use of amlodipine may be:
- Very often: peripheral edema (feet and ankles) - in 1 of 10 users
- Often: dizziness, palpitations, muscle, stomach or headache, dyspepsia, nausea - in 1 in 100 users
- Sometimes: blood disorders, development of breasts in men (gynecomastia), impotence, depression, insomnia, tachycardia - in 1 in 1,000 users
- Rarely: erratic behavior, hepatitis, jaundice - in 1 in 10,000 users
- Very rarely: hyperglycemia, tremor, Stevens-Johnson syndrome - in 1 in 100,000 users
Source: Sandoz product information sheet
[edit] Dose
- Hypertension or angina: 5 or 10 mg once daily.
[edit] Salts
In the United Kingdom tablets of amlodipine from different suppliers may contain different salts. The strength of the tablets is expressed in terms of amlodipine base. i.e. without the salt. Tablets containing different salts are therefore considered interchangeable.
[edit] Patent loss
Pfizer patent protection on Norvasc until 2007. [1]
[edit] External links
- Norvasc - Prescription Drug Info Amlodipine Profile
- Istin - Summary of Product Characteristics from the electronic Medicines Compendium
Calcium channel blockers (C08) edit | ||
---|---|---|
Dihydropyridines: |
Amlodipine, Felodipine, Isradipine, Lacidipine, Lercanidipine, Nicardipine, Nifedipine, Nimodipine, Nisoldipine |
|
Phenylalkylamines: | ||
Benzothiazepines: |